Why some African nations are turning down Trump aid money

The Trump administration is re-engaging African nations with offers of hundreds of millions of dollars for healthcare and disease prevention. However, these new aid packages come with conditions that are prompting resistance from some governments.

“

We hope to sign, I don't know, 30, 40, how many? Fifty? Well, this is number one. We'll always remember this one… and we think we've picked the perfect partner.

Unlike previous aid structures, the State Department's new global health strategy mandates that recipient countries share responsibility by increasing their own health spending. The goal is to build self-reliant, durable health systems. For example, the U.S. is contributing $1.6 billion to a deal with Kenya, which has pledged $850 million over five years.

Administration officials state this approach aims to improve upon traditional donor-NGO relationships, which they claim created dependency and incurred high overhead costs. They assert that partnering directly with national leadership will empower countries to manage their own health programs. "Our aid to those countries will not just be dollars distributed to an NGO who then will go into the country and impose programmes," said U.S. Secretary of State Marco Rubio. "Not only are we treating the acute situations on the ground of people that are sick, we are helping them build the capacity and the capability to do this for themselves."

“

Our aid to those countries will not just be dollars distributed to an NGO who then will go into the country and impose programmes. Not only are we treating the acute situations on the ground of people that are sick, we are helping them build the capacity and the capability to do this for themselves.

This shift moves away from global cooperation anchored in the World Health Organization (WHO) towards direct bilateral agreements. These agreements are reportedly tied to U.S. strategic and commercial interests, controversially including an explicit promise to prioritize U.S. pharmaceutical and medical firms in developing and delivering treatments. "Our global health foreign assistance programme is not just aid - it is a strategic mechanism to further our bilateral interests around the world," states a policy document.

“

Our global health foreign assistance programme is not just aid - it is a strategic mechanism to further our bilateral interests around the world.